Citalopram hydrobromide and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Citalopram hydrobromide (citalopram hydrobromide), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Metronidazole, and have Breast cancer.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Citalopram hydrobromide. It is created by eHealthMe based on reports of 32,819 people who have side effects when taking Citalopram hydrobromide from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,880 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,963 drugs and 1,976 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

32,819 people reported to have side effects when taking Citalopram hydrobromide.
Among them, 96 people (0.29%) have Dermatitis - atopic.

Could Citalopram hydrobromide cause Dermatitis - atopic?

Among these 96 people:

How long have people been on Citalopram hydrobromide when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Citalopram hydrobromide? *

female: 88.64 %
male: 11.36 %

What is the age of people who have Dermatitis - atopic when taking Citalopram hydrobromide? *

What are other drugs people take besides Citalopram hydrobromide? *

What are other side effects people have besides Dermatitis - atopic? *

Anaemia (lack of blood): 51 people, 53.12%
Pain: 49 people, 51.04%
Dyspnea (difficult or laboured breathing): 48 people, 50.00%
Constipation: 47 people, 48.96%
Bone Disorder: 47 people, 48.96%
Weakness: 46 people, 47.92%
Back Pain: 45 people, 46.88%
Fatigue (feeling of tiredness): 43 people, 44.79%
Rashes (redness): 43 people, 44.79%
Impaired Healing: 41 people, 42.71%

What are the existing conditions these people have? *

Breast Cancer: 31 people, 32.29%
High Blood Pressure: 21 people, 21.88%
Breast Cancer Metastatic: 16 people, 16.67%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 16 people, 16.67%
Asthma: 16 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 13 people, 13.54%
Pain: 11 people, 11.46%
Fatigue (feeling of tiredness): 11 people, 11.46%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 11.46%
Bone Pain: 9 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Citalopram hydrobromide:

Citalopram hydrobromide (36,880 reports)

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,963 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,976 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Citalopram hydrobromide) and Citalopram hydrobromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.